Pharma tariffs ‘not a huge risk’ for domestic companies, says Mizuho’s Jared Holz

CNBC’s “Fast Money” team discusses the potential impact of pharmaceutical tariffs with Jared Holz, healthcare equity strategist at Mizuho.